During the past decade, Kansas City CCOP conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 9 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kansas City CCOP" #1 sponsor was "National Cancer Institute (NCI)" with 7 trials, followed by "SWOG Cancer Research Network" with 3 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "Canadian Cancer Trials Group" with 1 trials sponsored and "Eastern Cooperative Oncology Group" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kansas City CCOP" #1 collaborator was "National Cancer Institute (NCI)" with 7 trials as a collaborator, "ETOP IBCSG Partners Foundation" with 1 trials as a collaborator, "Eastern Cooperative Oncology Group" with 1 trials as a collaborator, "ICR-CTSU" with 1 trials as a collaborator and "NCIC Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Kansas City CCOP" are "Breast Cancer" (2 trials), "Recurrent Melanoma" (2 trials), "Acral Lentiginous Malignant Melanoma" (1 trials), "Adenocarcinoma of the Gastroesophageal Junction" (1 trials) and "Adult Nasal Type Extranodal NK/T-Cell Lymphoma" (1 trials). Many other conditions were trialed in "Kansas City CCOP" in a lesser frequency.

Most popular intervention types in "Kansas City CCOP" are "Drug" (14 trials), "Other" (8 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (5 trials), "Paclitaxel" (5 trials), "Carboplatin" (3 trials), "Bevacizumab" (2 trials) and "Pharmacological Study" (2 trials). Other intervention names were less common.

The vast majority of trials in "Kansas City CCOP" are 12 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Kansas City CCOP". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Kansas City CCOP, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Kansas City CCOP, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".